Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)
NCT: NCT07135284 · RECRUITING
Brief Summary
The purpose of this study is to collect data to assess the use of the LibAirty™ System for improving bronchiectasis symptoms and healthcare resource utilization when it is used at home. The main question this study is trying to answer is: How often do adults with bronchiectasis experience pulmonary exacerbations (flare-ups of their lung condition) while using the LibAirty™ airway clearance system at home? Participants will use the LibAirty™ airway clearance system at home as prescribed by their doctor - the device is not being provided as part of the study. The study will last for 12 months from the time participants begin using LibAirty. During the study period, participants will continue with their usual clinic visits. At some of these regular visits (up to 4 times over the year), participants will be asked to complete short questionnaires about their bronchiectasis symptoms and their experience using LibAirty. At these same visits, the study team will also review participants' medical records and collect information related to their bronchiectasis condition, such as test results, medications, and any hospital or emergency room visits.
Frequently Asked Questions
What is Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)?
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS) is a clinical trial registered under NCT07135284. Current status: RECRUITING.
What is the status of NCT07135284?
The current status of NCT07135284 (Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS)) is: RECRUITING.
When did Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS) start?
Real Life Evaluation of the LibAirty Airway Clearance System in Adults With Bronchiectasis (RELACS) started on 2025-08-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.